Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Bilgin Comert"'
Publikováno v:
Canadian Respiratory Journal, Vol 2020 (2020)
Objective. Oxygen therapy is one of the most common treatment modalities for hypoxemic patients, but target goals for normoxemia are not clearly defined. Therefore, iatrogenic hyperoxia is a very common situation. The results from the recent clinical
Externí odkaz:
https://doaj.org/article/27a6157cec714b50bf1a1282f4a26dea
Autor:
Ahmet Ozturk, Levent Yamanel, Salim Ozenc, Mehmet Ince, Kemal Simsek, Bilgin Comert, Bulent Uysal, Halil Erturk, Umit Kaldirim, Turgut Topal, Serdar Sadir, Kenan Saglam
Publikováno v:
Archives of Clinical and Experimental Surgery, Vol 5, Iss 1, Pp 7-12 (2016)
Introduction: Several studies have been done on sepsis and many therapeutic agents have been developed. All agents were tested on animals prior to trials in humans. In this study, our aim was to investigate the healing effects of hyperbaric oxygen (H
Externí odkaz:
https://doaj.org/article/79ffcb835c3b4d1ebc461f2543fa985e
Autor:
Mehmet Celal Öztürk, Yasin Levent Uğur, Begüm Ergan, Bilgin Comert, Murat Küçük, Necati Gokmen
Publikováno v:
Turkish Journal of Intensive Care. 20:214-219
Autor:
Murat Kucuk, Cihan Heybeli, Mehmet Celal Ozturk, Bişar Ergun, Mehmet Nuri Yakar, Ali Necati Gokmen, Bilgin Comert, Begüm Ergan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f27468f5e049d7f6afcdb1bf05b330
https://avesis.deu.edu.tr/publication/details/73ee0ada-2962-43d4-b389-cf96dcbc70e9/oai
https://avesis.deu.edu.tr/publication/details/73ee0ada-2962-43d4-b389-cf96dcbc70e9/oai
Autor:
Beril Turan Erdoğan, Huseyin Ozkok, Taner Çalışkan, Vedat Uygun, Yusuf Savran, Bilgin Comert, Murat Küçük
Publikováno v:
Türk Yoğun Bakim Derneği Dergisi, Vol 19, Iss 4, Pp 200-204 (2021)
Pneumatosis intestinalis (PI) is a rare disease, which presents a wide range of severity. Numerous etiologies, including trauma, inflammation, infections, autoimmunity, drugs, and mechanical procedures, gave rise to this complication. Abdominal compu
Publikováno v:
Turk Thorac J
OBJECTIVE: Drowning is a process of submersion and can lead to respiratory failure. Annually, there are an estimated 320 000 deaths worldwide due to drowning, in addition to nonfatal drowning events. There are limited data for respiratory failure due
Autor:
Necati Gokmen, Ferhan Demirer Aydemir, Nuri M Yakar, Gokalp A Utkugun, Reyhan Uçku, Bilgin Comert, Ayse Gelal, Seyma Oncu
Publikováno v:
International Journal of Clinical Practice. 75
OBJECTIVE To determine the prevalence of and the risk factors for Potentially Inappropriate Medication (PIM), the drug groups most commonly evaluated as PIMs in elderly patients in the ICUs by using 2019 Beers Criteria, STOPP version 2 (v2) Criteria
A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(8)
Introduction Developments in targeted molecular therapies have considerably improved patient survival in cancer. Panitumumab is a monoclonal antibody against the epidermal growth factor receptor (EGFR). It is used to treat metastatic colorectal carci
Autor:
Ali Necati Gökmen, Bişar Ergün, Erdem Yaka, Ali Cantürk, Mahmut Cem Ergon, Bilgin Comert, Mehmet Nuri Yakar, Naciye Sinem Gezer, Murat Küçük, Begüm Ergan
Publikováno v:
Turkish Journal of Medical Sciences
Background: To date, the coronavirus disease 2019 (COVID-19) caused more than 2.6 million deaths all around the world. Risk factors for mortality remain unclear. The primary aim was to determine the independent risk factors for 28-day mortality. Mate
Autor:
Begüm Ergan, Mehmet Nuri Yakar, Melih Kaan Sözmen, Erdem Yaka, Ali Necati Gökmen, Bişar Ergün, Murat Küçük, Bilgin Comert
Publikováno v:
Journal of Arrhythmia, Vol 37, Iss 5, Pp 1196-1204 (2021)
Journal of Arrhythmia
Journal of Arrhythmia
Background Mortality in critically ill patients with coronavirus disease 2019 (COVID‐19) is high, therefore, it is essential to evaluate the independent effect of new‐onset atrial fibrillation (NOAF) on mortality in patients with COVID‐19. We a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c81d7c1462d8f75f8d7dfb52ec2409
https://doi.org/10.22541/au.161625416.61272781/v1
https://doi.org/10.22541/au.161625416.61272781/v1